Pharmaceuticals

AstraZeneca will have the option to obtain exclusive rights to develop, manufacture and commercialise one preclinical small nucleic acid drug candidate globally.

International

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

CSPC is eligible to receive US$30 million as upfront payment and up to US$1.7 billion in additional payments

This marks a significant expansion of GSK’s cancer portfolio, which has been slowly growing since it returned to the disease space in 2019.

Consumer & Healthcare

GSK to buy Nuvalent for US$10.6 billion to expand in cancer drugs

The British firm will pay US$124 a share for Nuvalent

The transaction is expected to close later this year.

Consumer & Healthcare

J&J to buy cancer drug technology developer Firefly Bio for US$1 billion

JOHNSON & Johnson said on Monday (Jun 8) it will acquire biotech Firefly Bio for US$1 billion in cash, as it looks to expand its cancer drug pipeline.

In what appears to be a first, a presentation of a clinical trail conducted exclusively in China will be a headliner at this year's American Society of Clinical Oncology meeting.

International

China’s rise in drug development looms over US

China’s ascendence as a drug development powerhouse could threaten US biotechnology

A pharmaceutical firm in India has launched a weight-loss injection that costs from 1,290 rupees (S$17) a month.

Opinion & Features

THINKING ALOUD

A GLP-1 tsunami is headed for the vice industry. Good.

A new wave of cheap weight-loss drugs heralds an existential crisis for the sin economy

Sun Pharma, valued at more than US$40 billion, plans to fund the acquisition through a combination of available cash resources and committed financing from banks.

Companies & Markets

India’s Sun Pharma to buy US-listed Organon in about US$11.8 billion deal

Sun Pharma will buy all the outstanding shares of Organon for US$14 per share

Zuellig Pharma’s Changi warehouse and distribution centre in Singapore, established in 2009.

Companies & Markets

Competition watchdog seeks public feedback on Zuellig Pharma-Eli Lilly deal

Pact includes Zuellig Pharma getting exclusive rights to make erectile dysfunction drug Cialis in Singapore

The transaction will strengthen Novartis’ presence in the market of immunology in food allergy.

Companies & Markets

Novartis to buy US-based biotech firm Excellergy for up to US$2 billion

The transaction is expected to close in the second half of 2026

Pfizer secured China rights to the therapy from local startup Hangzhou Sciwind Bioscience in a US$495 million deal in late February.

Companies & Markets

Pfizer secures China nod for obesity drug as generics loom

Pfizer now enters a field dominated by multinational rivals

Executives of Gilead have made it clear the company is hunting for deals to supplement its core portfolio of antivirals into cancer and other areas.

Companies & Markets

Gilead to buy US biotech Arcellx for up to US$7.8 billion

The US drugmaker seeks to boost its cancer drug pipeline

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News